Recent publications

  • Doctors of the World opposes the patent on sofosbuvir Hepatitis C: scourge, remedy and scandal

  • Gilead: Stop Blocking Access to Hepatitis C Treatment Thousands of activists urge company to change its policies on eve of shareholder meeting

  • Civil Society Groups Tell UNITAID: Support access mechanisms led by civil society, not the pharmaceutical industry Letters from global groups express deep concerns about the Medicines Patent Pool’s entry into hepatitis C treatment